特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のデジタルパソロジー市場:成長、動向、および予測(2020年~2025年)

Digital Pathology Market - Growth, Trends, and Forecasts (2020 - 2025)

発行 Mordor Intelligence LLP 商品コード 808302
出版日 ページ情報 英文 114 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.13円で換算しております。
世界のデジタルパソロジー市場:成長、動向、および予測(2020年~2025年) Digital Pathology Market - Growth, Trends, and Forecasts (2020 - 2025)
出版日: 2020年06月01日 ページ情報: 英文 114 Pages
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
概要

当レポートは世界のデジタルパソロジー市場について調査しており、市場機会や動向、成長および阻害要因、製品・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 成長要因
    • 遠隔相談件数の増加
    • ラボの効率を高めるためのデジタルパソロジーの採用増加
    • 創薬およびコンパニオン診断における用途の増加
  • 阻害要因
    • 一次診断に関する厳しい規制上の懸念
    • デジタルパソロジーのための標準ガイドラインの欠如
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメンテーション

  • 製品別
    • スキャナー
    • ソフトウェア
    • ストレージシステム
    • その他
  • 用途別
    • 病気の診断
    • 創薬
    • 教育・トレーニング
  • エンドユーザー別
    • 医薬品、バイオテクノロジー、企業、CRO
    • 病院、リファレンス研究所
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • 3DHistech Ltd.
    • Definiens AG
    • 浜松ホトニクス株式会社
    • Leica Biosystems Nussloch GmBH
    • Mikroscan Technologies Inc.
    • 株式会社ニコン
    • オリンパス株式会社
    • Koninklijke Philips NV
    • Ventana Medical Systems Inc.
    • VISIONPHARM

第7章 市場機会および今後の動向

目次
Product Code: 52875

The increasing number of teleconsultations, rising adoption of digital pathology to enhance lab efficiency, and increasing application in drug discovery and companion diagnostics are driving the digital pathology market. Moreover, the investment in laboratory expansion and market penetration of key manufacturers are likely to propel the market growth.

Teleconsultation aims to omit geographical and functional distances between two or more geographically separated healthcare providers. It is defined as the consultation by remote telecommunications, primarily for the diagnosis or treatment of a patient at sites that are distant from the patients or primary physicians. Teleconsultation services are being implemented by several hospitals, primary healthcare physicians, private medical practices, and other medical units. Thus, it has proven to be feasible and effective, to potentially reduce costs, provide organizational benefits, and improve patient's satisfaction.

The use of digital pathology in disease diagnosis is also increasing, due to the integration of digital pathology with digital tools, barcoding, specimen tracking, and digital dictation, which improves the safety, quality, and efficiency of disease diagnoses in pathology laboratories.

The market is also expected to be driven by the increasing adoption of telepathology, rising investment in healthcare in developed countries, market penetration of key manufacturers in the developing region, and an increasing focus on drug discovery.

Key Market Trends

Disease Diagnosis is Expected to Grow the Fastest by Application, over the Forecast Period

For the diagnosis of diseases, digital pathology encompasses different technologies, which include laboratory management systems, digital dictation, dashboards and workflow management, digital image analysis, electronic specimen labeling and tracking, and synoptic reporting tools. Therefore, the integration of digital pathology, along with digital tools, barcoding, specimen tracking, and digital dictation, improves the safety, quality, and efficiency of disease diagnoses in pathology laboratories. Hence, owing to the advantages of using digital pathology for disease diagnoses, the market is expected to grow significantly, over the forecast period.

Asia-Pacific is the Fastest-growing Region and is Expected to Follow the Same Trend over the Forecast Period

The Asia-Pacific digital pathology market is anticipated to exhibit the fastest CAGR during the forecast period, due to the proliferation of advanced imaging modalities in emerging economies, growing investments in the medical field, and the presence of untapped opportunities. Thus, the presence of a large target patient population and booming healthcare industry are encouraging the growth of the regional market.

North America is expected to dominate the overall market throughout the forecast period. The presence of high per capita healthcare expenditure, increasing investment from key players, and the well-established IT and healthcare infrastructure are some of the factors contributing to the growth of the market studied in the region.

Competitive Landscape

The key players in the digital pathology market are adopting strategies, such as mergers and acquisitions, technological developments, and geographical expansions, in order to capture a significant position. Several manufacturers are focusing on developing digital pathology scanners with high throughput, improved resolution, high magnification, and high-end microscopes with automated scanning, which are expected to drive the market growth during the forecast period.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

Table of Contents

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing Number of Tele-consultations
    • 4.2.2 Rising Adoption of Digital Pathology to Enhance Lab Efficiency
    • 4.2.3 Increasing Application in Drug Discovery and Companion Diagnostics
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Concerns for Primary Diagnosis
    • 4.3.2 Lack of Standard Guidelines for Digital Pathology
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product
    • 5.1.1 Scanner
    • 5.1.2 Software
    • 5.1.3 Storage Systems
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Disease Diagnosis
    • 5.2.2 Drug Discovery
    • 5.2.3 Education and Training
  • 5.3 By End User
    • 5.3.1 Pharmaceutical, Biotechnology, Companies, and CROs
    • 5.3.2 Hospital and Reference Laboratories
    • 5.3.3 Other End Users
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3DHistech Ltd
    • 6.1.2 Hamamatsu Photonics KK
    • 6.1.3 Leica Biosystems Nussloch GmbH
    • 6.1.4 Mikroscan Technologies Inc.
    • 6.1.5 Nikon Corporation
    • 6.1.6 Olympus Corporation
    • 6.1.7 Koninklijke Philips NV
    • 6.1.8 Ventana Medical Systems Inc.
    • 6.1.9 VISIONPHARM

7 MARKET OPPORTUNITIES AND FUTURE TRENDS